BASEL, December 19, 2022 – Mosanna Therapeutics, a preclinical-stage Biotech company focused on developing MOS-118, a pharmacologic therapy to treat obstructive sleep apnea (OSA), today announced that the CEO will participate in the Partnering Forum at the Biotech Showcase 2023 taking place in San Francisco, January 9-11, and virtually between January 17-18. Meeting schedules will...Read More